Ovarian carcinomas, including secondary tumors: diagnostically challenging areas
- PMID: 15492758
- DOI: 10.1038/modpathol.3800312
Ovarian carcinomas, including secondary tumors: diagnostically challenging areas
Abstract
The differential diagnosis of ovarian carcinomas, including secondary tumors, remains a challenging task. Mucinous carcinomas of the ovary are rare and can be easily confused with metastatic mucinous carcinomas that may present clinically as a primary ovarian tumor. Most of these originate in the gastrointestinal tract and pancreas. International Federation of Gynecology and Obstetrics (FIGO) stage is the single most important prognostic factor, and stage I carcinomas have an excellent prognosis; FIGO stage is largely related to the histologic features of the ovarian tumors. Infiltrative stromal invasion proved to be biologically more aggressive than expansile invasion. Metastatic colon cancer is frequent and often simulates ovarian endometrioid adenocarcinoma. Although immunostains for cytokeratins 7 and 20 can be helpful in the differential diagnosis, they should always be interpreted in the light of all clinical information. Occasionally, endometrioid carcinomas may exhibit a microglandular pattern simulating sex cord-stromal tumors. However, typical endometrioid glands, squamous differentiation, or an adenofibroma component are each present in 75% of these tumors whereas immunostains for calretinin and alpha-inhibin are negative. Endometrioid carcinoma of the ovary is associated in 15-20% of the cases with carcinoma of the endometrium. Most of these tumors have a favorable outcome and they most likely represent independent primary carcinomas arising as a result of a Mullerian field effect. Although the criteria for distinguishing metastatic from independent primary carcinomas rely mainly upon conventional clinicopathologic findings, loss of heterozygosity and gene mutation analyses can be helpful. Transitional cell carcinomas are distinguished from undifferentiated carcinomas by the presence of thick, undulating papillae with smooth luminal borders, microspaces, and tumor cells with distinctive 'urothelial' appearance. Krukenberg tumors are metastatic adenocarcinomas traditionally perceived as composed of mucin-filled signet-ring cells associated with a striking proliferation of the ovarian stroma but many variations on this pattern occur.
Similar articles
-
Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.Mod Pathol. 2005 Feb;18 Suppl 2:S61-79. doi: 10.1038/modpathol.3800310. Mod Pathol. 2005. PMID: 15761467 Review.
-
Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis.Hum Pathol. 2005 Jun;36(6):605-19. doi: 10.1016/j.humpath.2005.03.005. Hum Pathol. 2005. PMID: 16021566
-
From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.Adv Anat Pathol. 2007 May;14(3):149-77. doi: 10.1097/PAP.0b013e3180504abf. Adv Anat Pathol. 2007. PMID: 17452813 Review.
-
Necrosis in 84 ovarian carcinomas: a morphologic study of primary versus metastatic colonic carcinoma with a selective immunohistochemical analysis of cytokeratin subtypes and carcinoembryonic antigen.Int J Gynecol Pathol. 1997 Jul;16(3):245-9. Int J Gynecol Pathol. 1997. PMID: 9421090
-
Sertoliform endometrioid carcinomas of the ovary: a clinicopathologic and immunohistochemical study of 13 cases.Mod Pathol. 1999 Oct;12(10):933-40. Mod Pathol. 1999. PMID: 10530556
Cited by
-
Ovarian metastases of pancreatic adenocarcinoma: clinical presentation, role of surgery, and potential value of the mutational profile for the differential diagnosis with primary mucinous ovarian carcinoma.Ther Adv Med Oncol. 2021 Oct 26;13:17588359211053412. doi: 10.1177/17588359211053412. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34721673 Free PMC article.
-
Metastatic ovarian tumor from pancreatic cancer treated with combined immunotherapy: A case report.Oncol Lett. 2022 Aug 17;24(4):344. doi: 10.3892/ol.2022.13464. eCollection 2022 Oct. Oncol Lett. 2022. PMID: 36072000 Free PMC article.
-
Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer.BMC Cancer. 2012 Aug 29;12:379. doi: 10.1186/1471-2407-12-379. BMC Cancer. 2012. PMID: 22931248 Free PMC article.
-
The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review.Clin Exp Metastasis. 2017 Jun;34(5):295-307. doi: 10.1007/s10585-017-9856-8. Epub 2017 Jul 20. Clin Exp Metastasis. 2017. PMID: 28730323 Free PMC article. Review.
-
Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal: a Gynecologic Oncology Group study.Cancer. 2011 Feb 1;117(3):554-62. doi: 10.1002/cncr.25460. Epub 2010 Sep 22. Cancer. 2011. PMID: 20862744 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous